Lin Pan
Impact in
- Gastroenterology top 10%
- Gastrointestinal motility and disorders
-
- Mesenchymal stem cell research
Papers in
- Immunology 11
- Atherosclerosis and Cardiovascular Diseases 4
- Co-authors
- Jianyan Wen (6 shared papers)Guangwei Li (4 shared papers)Zhiqiang Hou (2 shared papers)Hongliang Li (2 shared papers)Peng Liu (5 shared papers)Menglin Zhang (3 shared papers)Yuquan Zhang (3 shared papers)Honglan Zhu (3 shared papers)
- Journals
- Evidence-based Complementary and Alternative Medicine (4 papers)Blood (3 papers)Frontiers in Physiology (3 papers)International Immunopharmacology (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Lin Pan
87 papers receiving 1.3k citations
Lin Pan's Hit Papers
Peers
Comparison fields: 5 of 143
- Gastroenterology 39
- Genetics 71
- Complementary and alternative medicine 51
- Pulmonary and Respiratory Medicine 157
- Ophthalmology 40
Countries citing papers authored by Lin Pan
This map shows the geographic impact of Lin Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Pan more than expected).
Fields of papers citing papers by Lin Pan
This network shows the impact of papers produced by Lin Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Pan. The network helps show where Lin Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 82 | |
| 2 | 2016 | 75 | |
| 3 | Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice Hit paper breakdown → | 2023 | 74 |
| 4 | 2008 | 64 | |
| 5 | 2016 | 56 | |
| 6 | 2023 | 55 | |
| 7 | 2019 | 54 | |
| 8 | 2011 | 50 | |
| 9 | 2015 | 48 | |
| 10 | 2008 | 40 | |
| 11 | 2008 | 39 | |
| 12 | 2018 | 37 | |
| 13 | 2018 | 31 | |
| 14 | 2024 | 30 | |
| 15 | 2017 | 29 | |
| 16 | Transplantation of human amnion mesenchymal cells attenuates the disease development in rats with collagen-induced arthritis. | 2015 | 28 |
| 17 | 2020 | 27 | |
| 18 | 2005 | 24 | |
| 19 | 2008 | 24 | |
| 20 | 2019 | 22 |
About Lin Pan
Lin Pan is a scholar working on Molecular Biology, Immunology, Pulmonary and Respiratory Medicine, Surgery and Physiology, having authored 91 papers that have together received 1.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Hemoglobinopathies and Related Disorders (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Diabetes and associated disorders (3 papers), Plant responses to water stress (3 papers), Pancreatic function and diabetes (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Advanced X-ray Imaging Techniques (3 papers). The work is most often cited by research in Gastroenterology (39 citations), Genetics (71 citations), Complementary and alternative medicine (51 citations), Pulmonary and Respiratory Medicine (157 citations) and Ophthalmology (40 citations). Lin Pan has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jianyan Wen, Guangwei Li, Zhiqiang Hou, Hongliang Li, Peng Liu, Menglin Zhang, Yuquan Zhang, Honglan Zhu, Shukun Yao and Qiang Wang. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Blood, Frontiers in Physiology, International Immunopharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.